Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-12-05
2006-12-05
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S331000
Reexamination Certificate
active
07144889
ABSTRACT:
Compounds of the general formula (I)are presented and are valuable therapeutics for the treatment of cancer and cancer related diseases.
REFERENCES:
patent: 5656644 (1997-08-01), Adams et al.
patent: 6610695 (2003-08-01), Adams et al.
patent: WO 96/18626 (1996-06-01), None
patent: WO 01/44154 (2001-06-01), None
patent: WO 03/087026 (2003-10-01), None
Herynk et al., Medline Abstract (Cancer Research, vol. 63, Issue 11, pp. 2990-2996) Jun. 2003.
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010, 1996.
Traxler, Protein Tyrosine Kinase Inhibitors in cancer treatment, Exp. Opin. Ther. Patents, 7(6):571-588, 1997.
Thomas Von Hirschheydt et al, Synthesis, No. 12, pp. 2062-2065 (2004).
von Hirschheydt Thomas
Voss Edgar
Hoffman-La Roche Inc.
Johnston George W.
Rao Deepak
Remy Brian C.
Rocha-Tramaloni Patricia S.
LandOfFree
Triarylimidazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triarylimidazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triarylimidazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3701436